Breaking News, Collaborations & Alliances

Fujifilm, Merck Partner on $60M Microbial Biologics Facility

New 20,000-liter facility to be used by Fujifilm for its contract development and manufacturing customers

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fujifilm Diosynth Biotechnologies, a global biologics contract development and manufacturing organization (CDMO), said that it is in the process of establishing a long-term collaboration with Merck to invest in and operate a new 20,000 liter large-scale microbial-biologics facility for supply of active pharmaceutical ingredient (API) to its customers. This collaboration involves a $60 million investment by Merck at its Brinny manufacturing plant in Innishannon, County Cork, Ireland. Merck in ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters